Professor Peter Youssef

Clinical Professor
Discipline of Medicine, Central Clinical School

Telephone 02 95159337
Fax 02 95159466

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Boulos, D., Ngian, G., Elford, K., Stevens, W., Proudman, S., Owen, C., Roddy, J., Nikpour, M., Youssef, P., Hill, C., et al (2017). Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. International Journal of Rheumatic Diseases, 20(4), 481-488. [More Information]
  • Jee, A., Adelstein, S., Bleasel, J., Keir, G., Nguyen, M., Sahhar, J., Youssef, P., Corte, T. (2017). Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine, 6(5), 1-23. [More Information]
  • Owen, C., Ngain, G., Elford, K., Moore, O., Stevens, W., Nikpour, M., Rabusa, C., Proudman, S., Roddy, J., Youssef, P., et al (2016). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Clinical and Experimental Rheumatology, 34(Suppl. 100), S170-S176.
  • Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., Walker, J., Roddy, J., Lester, S., Rischmueller, M., Youssef, P., et al (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(Suppl 100), 129-136.
  • Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(7), 1-11. [More Information]
  • Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140. [More Information]
  • Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., Morrisroe, K., Thakkar, V., Sahhar, V., Roddy, J., Youssef, P., et al (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(Suppl 91), S111-S116.
  • Nicholls, D., Zochling, J., Boers, A., Champion, G., Mathers, D., Riordan, J., Youssef, P., Scott, J., Griffiths, H. (2014). A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice. International Journal of Rheumatic Diseases, 17(7), 755-761. [More Information]
  • Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R., Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening and Treating Pulmonary Arterial Hypertension in a Tertiary Hospital-based Multidisciplinary Clinic: The First 200 Patients. Internal Medicine Journal, 43(1), 32-37. [More Information]
  • Lord, M., Day, A., Youssef, P., Zhuo, L., Watanabe, H., Caterson, B., Whitelock, J. (2013). Sulfation of the Bikunin Chondroitin Sulfate Chain Determines Heavy Chain - Hyaluronan Complex Formation. The Journal of Biological Chemistry, 288(32), 22930-22941. [More Information]
  • Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., Roddy, J., Walker, J., Zochling, J., Sahhar, J., et al (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research and Therapy, 15(6), 1-11. [More Information]
  • Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy, 14(3), 1-10. [More Information]
  • Lord, M., Estrella, R., Chuang, C., Youssef, P., Karlsson, N., Flannery, C., Whitelock, J. (2012). Not All Lubricin Isoforms Are Substituted with a Glycosaminoglycan Chain. Connective Tissue Research, 53(2), 132-141. [More Information]
  • Craig, S., Youssef, P., Vaile, J., Sullivan, L., Bleasel, J. (2011). Intravenous Zoledronate and Oral Alendronate in Patients with a Low Trauma Fracture: experience from an osteoporosis clinic. Internal Medicine Journal, 41(2), 186-190. [More Information]
  • Richards, B., Spies, J., McGill, N., Richards, G., Vaile, J., Bleasel, J., Youssef, P. (2007). Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Internal Medicine Journal, 37, 101-107. [More Information]
  • Youssef, P., Hsu, K., Passey, R., Endoh, Y., Rahimi, F., Yen, T., Geczy, C. (2005). Regulation of S100A8 by glucocorticoids. The Journal of Immunology, 174(4), 2318-26. [More Information]

2017

  • Boulos, D., Ngian, G., Elford, K., Stevens, W., Proudman, S., Owen, C., Roddy, J., Nikpour, M., Youssef, P., Hill, C., et al (2017). Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. International Journal of Rheumatic Diseases, 20(4), 481-488. [More Information]
  • Jee, A., Adelstein, S., Bleasel, J., Keir, G., Nguyen, M., Sahhar, J., Youssef, P., Corte, T. (2017). Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine, 6(5), 1-23. [More Information]

2016

  • Owen, C., Ngain, G., Elford, K., Moore, O., Stevens, W., Nikpour, M., Rabusa, C., Proudman, S., Roddy, J., Youssef, P., et al (2016). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Clinical and Experimental Rheumatology, 34(Suppl. 100), S170-S176.
  • Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., Walker, J., Roddy, J., Lester, S., Rischmueller, M., Youssef, P., et al (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(Suppl 100), 129-136.

2015

  • Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(7), 1-11. [More Information]
  • Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140. [More Information]
  • Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., Morrisroe, K., Thakkar, V., Sahhar, V., Roddy, J., Youssef, P., et al (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(Suppl 91), S111-S116.

2014

  • Nicholls, D., Zochling, J., Boers, A., Champion, G., Mathers, D., Riordan, J., Youssef, P., Scott, J., Griffiths, H. (2014). A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice. International Journal of Rheumatic Diseases, 17(7), 755-761. [More Information]

2013

  • Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R., Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening and Treating Pulmonary Arterial Hypertension in a Tertiary Hospital-based Multidisciplinary Clinic: The First 200 Patients. Internal Medicine Journal, 43(1), 32-37. [More Information]
  • Lord, M., Day, A., Youssef, P., Zhuo, L., Watanabe, H., Caterson, B., Whitelock, J. (2013). Sulfation of the Bikunin Chondroitin Sulfate Chain Determines Heavy Chain - Hyaluronan Complex Formation. The Journal of Biological Chemistry, 288(32), 22930-22941. [More Information]
  • Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., Roddy, J., Walker, J., Zochling, J., Sahhar, J., et al (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research and Therapy, 15(6), 1-11. [More Information]

2012

  • Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy, 14(3), 1-10. [More Information]
  • Lord, M., Estrella, R., Chuang, C., Youssef, P., Karlsson, N., Flannery, C., Whitelock, J. (2012). Not All Lubricin Isoforms Are Substituted with a Glycosaminoglycan Chain. Connective Tissue Research, 53(2), 132-141. [More Information]

2011

  • Craig, S., Youssef, P., Vaile, J., Sullivan, L., Bleasel, J. (2011). Intravenous Zoledronate and Oral Alendronate in Patients with a Low Trauma Fracture: experience from an osteoporosis clinic. Internal Medicine Journal, 41(2), 186-190. [More Information]

2007

  • Richards, B., Spies, J., McGill, N., Richards, G., Vaile, J., Bleasel, J., Youssef, P. (2007). Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Internal Medicine Journal, 37, 101-107. [More Information]

2005

  • Youssef, P., Hsu, K., Passey, R., Endoh, Y., Rahimi, F., Yen, T., Geczy, C. (2005). Regulation of S100A8 by glucocorticoids. The Journal of Immunology, 174(4), 2318-26. [More Information]

To update your profile click here. For support on your academic profile contact .